3 Drug Stocks That Soared This Week: Are They Buys?
Most investors would be quite happy to get a 20% return over the course of a year. Of course "happy" wouldn't begin to describe the feeling of getting an even better return than that in just a week. But that's just what three drug stocks did over the last five days, with two of them achieving much-higher gains.
Endocyte (NASDAQ: ECYT), MannKind (NASDAQ: MNKD), and Mylan (NASDAQ: MYL) saw their stocks soar this week after floundering for much of 2017. Let's see why these drug stocks took off -- and whether they're smart picks for investors.
Image source: Getty Images.
Source: Fool.com
Teva Pharmaceutical Industries Ltd ADR Stock
€15.40
-2.220%
Teva Pharmaceutical Industries Ltd ADR is currently one of the favorites of our community with 17 Buy predictions and no Sell predictions.
As a result the target price of 18 € shows a slightly positive potential of 16.88% compared to the current price of 15.4 € for Teva Pharmaceutical Industries Ltd ADR.
